Approvals/TGA/STILNOX CR Zolpidem tartrate 6.25mg modified release tablet blister pack

Approved

STANDARD

STILNOX CR Zolpidem tartrate 6.25mg modified release tablet blister pack

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8ff7a10059d2975a
Product Name: STILNOX CR Zolpidem tartrate 6.25mg modified release tablet blister pack
Artg Id: 120707
Artg Name: STILNOX CR Zolpidem tartrate 6.25mg modified release tablet blister pack
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2006-07-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05719-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05720-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8ff7a10059d2975a

Type

Standard